These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7740757)

  • 1. Partial characterization of a Moraxella bovis cytolysin.
    Gray JT; Fedorka-Cray PJ; Rogers DG
    Vet Microbiol; 1995 Feb; 43(2-3):183-96. PubMed ID: 7740757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and characterization of a Moraxella bovis cytotoxin gene.
    Angelos JA; Hess JF; George LW
    Am J Vet Res; 2001 Aug; 62(8):1222-8. PubMed ID: 11497442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability, antigenicity, and aggregation of Moraxella bovis cytolysin after purification and storage.
    George LW; Angelos JA; Ruehl WW
    Am J Vet Res; 2004 Jul; 65(7):977-83. PubMed ID: 15281658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of hemolysin of Moraxella bovis using a hemolysis-neutralizing monoclonal antibody.
    Billson FM; Harbour C; Michalski WP; Tennent JM; Egerton JR; Hodgson JL
    Infect Immun; 2000 Jun; 68(6):3469-74. PubMed ID: 10816500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phylogenetic analysis and genetic diversity of 3' region of rtxA gene from geographically diverse strains of Moraxella bovis, Moraxella bovoculi and Moraxella ovis.
    Farias LD; Maboni G; Matter LB; Scherer CF; Libardoni F; de Vargas AC
    Vet Microbiol; 2015 Aug; 178(3-4):283-7. PubMed ID: 26036790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic and protective characterization of Moraxella bovis pili.
    Lehr C; Jayappa HG; Goodnow RA
    Cornell Vet; 1985 Oct; 75(4):484-92. PubMed ID: 2865080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative characterization of the leukocidic and hemolytic activity of Moraxella bovis.
    Hoien-Dalen PS; Rosenbusch RF; Roth JA
    Am J Vet Res; 1990 Feb; 51(2):191-6. PubMed ID: 2301828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled field trial to assess efficacy of a Moraxella bovis pilin-cytotoxin-Moraxella bovoculi cytotoxin subunit vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis.
    Angelos JA; Gohary KG; Ball LM; Hess JF
    Am J Vet Res; 2012 Oct; 73(10):1670-5. PubMed ID: 23013196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An RTX operon in hemolytic Moraxella bovis is absent from nonhemolytic strains.
    Angelos JA; Hess JF; George LW
    Vet Microbiol; 2003 Apr; 92(4):363-77. PubMed ID: 12554105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Moraxella bovis and culture filtrates on 51Cr-labeled bovine neutrophils.
    Kagonyera GM; George L; Miller M
    Am J Vet Res; 1989 Jan; 50(1):18-21. PubMed ID: 2919823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Moraxella (Branhamella) ovis culture filtrates on bovine erythrocytes, peripheral mononuclear cells, and corneal epithelial cells.
    Cerny HE; Rogers DG; Gray JT; Smith DR; Hinkley S
    J Clin Microbiol; 2006 Mar; 44(3):772-6. PubMed ID: 16517853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis pilin-Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Bonifacio RG; Ball LM; Hess JF
    Vet Microbiol; 2007 Dec; 125(3-4):274-83. PubMed ID: 17656049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relatedness of cytotoxins from geographically diverse isolates of Moraxella bovis.
    Angelos JA; Ball LM
    Vet Microbiol; 2007 Oct; 124(3-4):382-6. PubMed ID: 17540518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproduction of bovine keratoconjunctivitis with a purified haemolytic and cytotoxic fraction of Moraxella bovis.
    Beard MK; Moore LJ
    Vet Microbiol; 1994 Sep; 42(1):15-33. PubMed ID: 7839582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of cell detachment activity induced by Moraxella bovis.
    Marrion RM; Riley LK
    Am J Vet Res; 2000 Sep; 61(9):1145-9. PubMed ID: 10976750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moraxella bovis pathogenicity: an update.
    Postma GC; Carfagnini JC; Minatel L
    Comp Immunol Microbiol Infect Dis; 2008 Nov; 31(6):449-58. PubMed ID: 18514312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental infectious bovine keratoconjunctivitis: efficacy of a vaccine prepared from nonhemolytic strains of Moraxella bovis.
    Pugh GW; McDonald TJ; Kopecky KE
    Am J Vet Res; 1982 Jun; 43(6):1081-4. PubMed ID: 7103179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALDI-TOF MS Biomarker Detection Models to Distinguish RTX Toxin Phenotypes of
    Hille MM; Clawson ML; Dickey AM; Lowery JH; Loy JD
    Front Cell Infect Microbiol; 2021; 11():632647. PubMed ID: 33796479
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of a capsular polysaccharide from Moraxella bovis.
    Wilson JC; Hitchen PG; Frank M; Peak IR; Collins PM; Morris HR; Dell A; Grice ID
    Carbohydr Res; 2005 Mar; 340(4):765-9. PubMed ID: 15721351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic characterization of Moraxella bovis, Moraxella bovoculi and Moraxella ovis strains with potential use in vaccines.
    Kowalski AP; Maboni G; Gressler LT; Espíndola JP; Balzan C; Tasca C; Guizzo JA; Conceição FR; Frandoloso R; de Vargas AC
    Vet Microbiol; 2017 Oct; 210():56-63. PubMed ID: 29103697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.